IMMUNOPD Trademark

Trademark Overview

On Thursday, July 16, 2026, a trademark application was filed for IMMUNOPD with the United States Patent and Trademark Office. The USPTO has given the IMMUNOPD trademark a serial number of 99943864. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, July 16, 2026. This trademark is owned by Novigenix AI SA. The IMMUNOPD trademark is filed in the Pharmaceutical Products and Medical & Beauty Services & Agricultural Services categories with the following description:

Medical and clinical diagnostic and prognostic testing services for laboratory analysis of blood samples to assess gene expression signatures and molecular biomarkers for the detection of disease, monitoring of disease status, and evaluation of patient responses to therapeutic treatment

Diagnostic preparations for analyzing blood samples to assess gene expression signatures and molecular biomarkers for the detection of disease, monitoring of disease status, and evaluation of patient response to therapeutic treatment; in vitro diagnostic reagents for detecting disease-associated molecular biomarkers in blood samples
immunopd

General Information

Serial Number99943864
Word MarkIMMUNOPD
Filing DateThursday, July 16, 2026
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateThursday, July 16, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesMedical and clinical diagnostic and prognostic testing services for laboratory analysis of blood samples to assess gene expression signatures and molecular biomarkers for the detection of disease, monitoring of disease status, and evaluation of patient responses to therapeutic treatment
Goods and ServicesDiagnostic preparations for analyzing blood samples to assess gene expression signatures and molecular biomarkers for the detection of disease, monitoring of disease status, and evaluation of patient response to therapeutic treatment; in vitro diagnostic reagents for detecting disease-associated molecular biomarkers in blood samples
Pseudo MarkIMMUNO PD
Pseudo MarkIMMUNO PROGRAMMED DEATH

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, July 16, 2026
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, July 16, 2026
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovigenix AI SA
Party Type10 - Original Applicant
Legal Entity Type33 - NOT AVAILABLE
AddressEpalinges 1066
CH

Trademark Events

Event DateEvent Description
Thursday, July 16, 2026APPLICATION FILING RECEIPT MAILED
Thursday, July 16, 2026NEW APPLICATION ENTERED

Related Keywords

immunopd disease samples molecular blood biomarkers diagnostic status detection evaluation patient